A systematic overview of radiation therapy effects in brain tumours

Acta Oncologica

Volumn 42, Issue 5-6, 2003, Pages 582-588

  Berg, Gertrud ^a   Blomquist, Erik ^b   Cavallin Ståhl, Eva ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CHEMOTHERAPY; FRACTIONATION; TUMORS;

RANDOMIZED STUDIES;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

ASTROCYTOMA; BRACHYTHERAPY; BRAIN CANCER; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; REVIEW;

ADULT; AGED; BRACHYTHERAPY; BRAIN NEOPLASMS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; QUALITY OF LIFE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME;

EID: 0141748422     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310014679     Document Type: Review

References (25)

1. Kleihues P, Burger PC, Scheithauer BW. World Health Organization international histological classification of tumours: histological typing of tumors of the central nervous system, 2nd ed., Berlin, Heidelberg: Springer-Verlag; 1993.
2. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999; 1: 44-51.
3. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323-9.
4. Andersen AP. Postoperative irradiation of glioblastomas. Results in a randomized series. Acta Radiol Oncol Radiat Phys Biol 1978; 17: 475-84.
5. Kristiansen K, Hagen S, Kollevold T, et al. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 1981; 47: 649-52.
6. Laperriere N, Zuraw L, Cairncross G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64: 259-73. (L1/1 773)
7. Scott CB. Quality-adjusted survival analysis of malignant glioma patients. Control Clin Trials 1997; 18: 277-85. (C1/786)
8. Werner-Wasik M, Scott CB, Nelson DF, et al. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Cancer 1996; 77: 1535-43. (C1/786)
9. Scott C, Curran W, Yung W, et al. Long term results of RTOG 9006: a randomized trial of hyperfractionated radiotherapy (RT) to 72.0 Gy & carmustine vs standard RT & carmustine for malignant glioma patients with emphasis on anaplastic astrocytoma (AA) patients. ASCO 1998; Abstr 1548.
10. Corn BW, Yousem DM, Scott CB, et al. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02). Cancer 1994; 74: 2828-35. (C1/747)
11. Sneed PK, McDermott MW, Gutin PH. Interstitial brachytherapy procedures for brain tumors. Semin Surg Oncol 1997; 13: 157-66. (L1)
12. Matsumoto K, Nakagawa T, Tada E, et al. Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas. Neurol Med Chir (Tokyo) 1997; 37: 891-9. (R3/83)
13. Laperriere NJ, Leung PM, McKenzie S, et al. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 1998; 41: 1005-11. (C2/140)
14. Brada M, Thomas G, Elyan S, et al. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma. Br J Cancer 1995; 71: 1330-4. (P1/116)
15. Hulshof MC, Schimmel EC, Andries Bosch D, et al. Hypofractionation in glioblastoma multiforme. Radiother Oncol 2000; 54: 143-8. (P1/155)
16. Huncharek M. Meta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma. Anticancer Res 1998; 18: 1935-9. (M2/1700)
17. Pickles T, Goodman GB, Rheaume DE, et al. Pion radiation for high grade astrocytoma: results of a randomized study. Int J Radiat Oncol Biol Phys 1997; 37: 491-7. (C2/81)
18. Donahue B, Scott CB, Nelson JS, et al. Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 1997; 38: 911-4. (C1/133)
19. Glinski B, Dymek P, Skolyszewski J. Altered therapy schedules in postoperative treatment of patients with malignant gliomas. Twenty-year experience of the Maria Sklodowska-Curie Memorial Center in Krakow, 1973-1993. J Neurooncol 1998; 36: 159-65. (R3/294)
20. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002; 52: 316-24. (C3/290)
21. Trautmann TG, Shaw EG. Supratentorial low-grade glioma: is there a role for radiation therapy? Ann Acad Med Singapore 1996; 25: 392-6. (L1)
22. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996; 36: 549-56. (C1/379)
23. Kiebert GM, Curran D, Aaronson NK, et al. Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group. Eur J Cancer 1998; 34: 1902-9. (C1/379)
24. Kreth FW, Faist M, Rossner R, et al. The risk of interstitial radiotherapy of low-grade gliomas. Radiother Oncol 1997; 43: 253-60. (R1/594)
25. Halperin EC. Malignant gliomas in older adults with poor prognostic signs. Getting nowhere, and taking a long time to do it. Oncology (Huntingt) 1995; 9: 229-34. (L2)